"Ubiquitin Thiolesterase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A thioester hydrolase which acts on esters formed between thiols such as DITHIOTHREITOL or GLUTATHIONE and the C-terminal glycine residue of UBIQUITIN.
| Descriptor ID |
D043222
|
| MeSH Number(s) |
D08.811.037.500 D08.811.277.352.897.850 D12.776.637.937
|
| Concept/Terms |
Ubiquitin Thiolesterase- Ubiquitin Thiolesterase
- Thiolesterase, Ubiquitin
- Ubiquitin C-Terminal Hydrolase
- C-Terminal Hydrolase, Ubiquitin
- Hydrolase, Ubiquitin C-Terminal
- Ubiquitin C Terminal Hydrolase
- Ubiquitin Carboxy-Terminal Hydrolase
- Carboxy-Terminal Hydrolase, Ubiquitin
- Hydrolase, Ubiquitin Carboxy-Terminal
- Ubiquitin Carboxy Terminal Hydrolase
- Ubiquitin C-Terminal Esterase
- C-Terminal Esterase, Ubiquitin
- Esterase, Ubiquitin C-Terminal
- Ubiquitin C Terminal Esterase
- Ubiquitin Carboxy-Terminal Esterase
- Carboxy-Terminal Esterase, Ubiquitin
- Esterase, Ubiquitin Carboxy-Terminal
- Ubiquitin Carboxy Terminal Esterase
Ubiquitin Carboxyl-Terminal Hydrolase Isozyme L1- Ubiquitin Carboxyl-Terminal Hydrolase Isozyme L1
- Ubiquitin Carboxyl Terminal Hydrolase Isozyme L1
- Parkinson Disease 5 Protein
- PARK5 Protein
- Neuron Cytoplasmic Protein 9.5
- UCHL1 Protein
- Uch-L1 Protein
- Uch L1 Protein
|
Below are MeSH descriptors whose meaning is more general than "Ubiquitin Thiolesterase".
Below are MeSH descriptors whose meaning is more specific than "Ubiquitin Thiolesterase".
This graph shows the total number of publications written about "Ubiquitin Thiolesterase" by people in this website by year, and whether "Ubiquitin Thiolesterase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 2 | 1 | 3 |
| 2012 | 2 | 1 | 3 |
| 2013 | 3 | 2 | 5 |
| 2014 | 0 | 1 | 1 |
| 2015 | 3 | 0 | 3 |
| 2016 | 2 | 1 | 3 |
| 2017 | 1 | 2 | 3 |
| 2018 | 2 | 3 | 5 |
| 2019 | 2 | 3 | 5 |
| 2020 | 0 | 2 | 2 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 3 | 3 |
| 2023 | 0 | 4 | 4 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ubiquitin Thiolesterase" by people in Profiles.
-
Diagnostic Performance of GFAP, UCH-L1, and MAP-2 Within 30 and 60 Minutes of Traumatic Brain Injury. JAMA Netw Open. 2024 Sep 03; 7(9):e2431115.
-
Multi-ancestry genome-wide association meta-analysis of Parkinson's disease. Nat Genet. 2024 Jan; 56(1):27-36.
-
Mesothelioma in situ of the peritoneum: report of three cases and review of the literature. Histopathology. 2024 Feb; 84(3):492-506.
-
UCHL1 Regulates Radiation Lung Injury via Sphingosine Kinase-1. Cells. 2023 10 05; 12(19).
-
Characterizing the distribution of alterations in mesothelioma and their correlation to morphology. Am J Clin Pathol. 2023 09 01; 160(3):238-246.
-
Ablation of EWS-FLI1 by USP9X inhibition suppresses cancer cell growth in Ewing sarcoma. Cancer Lett. 2023 01 01; 552:215984.
-
Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors. Mod Pathol. 2022 11; 35(11):1684-1694.
-
Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations. J Thorac Oncol. 2022 07; 17(7):873-889.
-
Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial. Nat Med. 2021 11; 27(11):1910-1920.
-
BAP1-Mutated Clear Cell Renal Cell Carcinoma. Am J Clin Pathol. 2021 04 26; 155(5):718-728.